Search results for " graft"

showing 10 items of 262 documents

Effects of a local single dose administration of growth hormone on the osseointegration of titanium implants.

2021

The aim of the present study was to evaluate the effect of different concentrations of growth hormone (GH) on endosteal implant?s surface at the early stages of osseointegration. Sixty tapered acid-etched titanium implants were divided into four groups: i) Collagen, used as a control group; and three experimental groups, where after collagen coating, GH was administered directly to the surface in varying concentrations: ii) 0.265 mg, iii) 0.53 mg, and iv) 1 mg. Implants were placed in an interpolated fashion in the anterior flange of C3, C4 or C5 of 15 sheep with minimum distance of 6 mm between implants. After 3-, 6- and 12-weeks of healing samples were harvested, histologically processed,…

Dental ImplantsTitaniumSheepSurface Propertiescortical graftaugmentation procedureonlay graftintraoral boneOtorhinolaryngologyOsseointegrationGrowth HormoneAnimalsSurgeryGeneral DentistryUNESCO:CIENCIAS MÉDICASMedicina oral, patologia oral y cirugia bucal
researchProduct

Rehabilitation of the severely atrophied dentoalveolar ridge in the aesthetic region with corticocancellous grafts from the iliac crest and dental im…

2016

Background The aim of this study was to assess changes in bone volume after block bone augmentation and placement of dental implants and further evaluate the aesthetic outcome of the treatment. Material and Methods 9 Patients with atrophied anterior maxilla were included in this study. They received total of 21 implants. Dimensions of the alveolar ridge were measured from cone-beam computed tomography x-rays. The bone level at the implant sites was analysed from intraoral x-rays and the aesthetic outcome was assessed from clinical photographs using a pink aesthetic score (PES) scaling. Results The mean gained horizontal bone width at the marginal crest and 5 mm apically was accordingly 2.7m…

DentistryIliac crest0302 clinical medicineMaxillaaesthetic regionOrthodonticsBone TransplantationDental Implantation EndosseousSoft tissueAlveolar Ridge AugmentationAlveolar Ridge Augmentation:CIENCIAS MÉDICAS [UNESCO]ANTERIOR MAXILLATreatment Outcomemedicine.anatomical_structure030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASAUGMENTATIONCONSECUTIVE PATIENTSOral Surgerysurvival ratepink aesthetic scoreEstheticsCONTROLLED CLINICAL-TRIALIlium03 medical and health sciencesRESTORATIONSmedicineAlveolar ridgeHumansRECONSTRUCTIONcorticocancellous bone graftsGeneral DentistrySurvival rateDental ImplantsSINGLE-TOOTH IMPLANTSbusiness.industrySOFT-TISSUEResearch030206 dentistry313 DentistryGUIDED BONE REGENERATIONOtorhinolaryngologyMaxillaSurgeryCrestImplantFOLLOW-UPbusinessFollow-Up StudiesMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Dual-Source Computed Tomography (DSCT) Angiography for the Visualization of Coronary Artery Bypass Grafts (CABG)

2007

Dual-Source Computed Tomography Coronary Artery Bypass GraftsSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Bioengineered vascular scaffolds: the state of the art

2014

To date, there is increasing clinical need for vascular substitutes due to accidents, malformations, and ischemic diseases. Over the years, many approaches have been developed to solve this problem, starting from autologous native vessels to artificial vascular grafts; unfortunately, none of these have provided the perfect vascular substitute. All have been burdened by various complications, including infection, thrombogenicity, calcification, foreign body reaction, lack of growth potential, late stenosis and occlusion from intimal hyperplasia, and pseudoaneurysm formation. In the last few years, vascular tissue engineering has emerged as one of the most promising approaches for producing …

EngineeringIntimal hyperplasiaBiomedical EngineeringMedicine (miscellaneous)ThrombogenicityNew materialsBioengineeringBiocompatible MaterialsVascular graftBiomaterialsTissue engineeringBlood vessel prosthesisBiomaterials; Tissue engineering; Vascular grafts; Vascular prosthesesmedicineHumansTissue engineeringTissue Scaffoldsbusiness.industrySettore ING-IND/34 - Bioingegneria IndustrialeGeneral Medicinemedicine.diseaseBiocompatible materialBiomaterialBlood Vessel ProsthesisStenosisSettore MED/18 - Chirurgia GeneraleVascular tissue engineeringVascular prosthesesbusinessBiomedical engineering
researchProduct

Assessment of coronary artery bypass grafts: value of different breath-hold MR imaging techniques.

1999

Our aim was to evaluate the patency of coronary artery bypass grafts and to detect graft stenosis using different breath-hold MR imaging techniques.Twenty-two patients with 59 grafts (14 internal mammary artery grafts and 45 saphenous vein grafts) and 76 distal anastomoses (singular and sequential grafts) were studied using a 1.5-T scanner. A two-dimensional T2-weighted breath-hold half-Fourier acquisition single-shot turbo spin echo (HASTE) sequence and a three-dimensional breath-hold contrast-enhanced MR angiography sequence (fast imaging with steady-state free precession) were performed. For MR angiography, a bolus of 20 ml of gadopentetate dimeglumine was used. Time delay for contrast i…

Gadolinium DTPAMalemedicine.medical_specialtyContrast MediaBypass graftsAnastomosisCoronary AngiographySensitivity and SpecificityBolus (medicine)Graft stenosisHumansMedicineRadiology Nuclear Medicine and imagingDerivationCoronary Artery BypassAgedbusiness.industryGraft Occlusion VascularGeneral MedicineMr imagingmedicine.anatomical_structureMammary arteryFemaleRadiologybusinessMagnetic Resonance AngiographyArteryAmerican Journal of Roentgenology
researchProduct

Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: A rare case report and review of the literature

2017

Abstract Background Oral verruciform xanthoma is an uncommon benign lesion. Although oral verruciform xanthoma occurs in healthy individuals, it has been also reported in association with some inflammatory conditions. The aim of this study is to report a case of oral verruciform xanthoma associated with chronic graft-versus-host disease and to review the literature on this topic. Case presentation A 47-year-old Caucasian male presented to the Sector of Oral Medicine “V. Margiotta”, University Policlinic “P. Giaccone” of Palermo complaining of a mass on the gingiva. He first noticed the painless mass 1 year ago. He reported to have undergone allogenic hematopoietic stem cell transplantation …

Genetics and Molecular Biology (all)MaleVerruciform xanthomaBiopsylcsh:MedicineGraft vs Host DiseaseCase ReportBiochemistryChronic graft versus-host-disease; Erythroplakia; Oral potential malignant disorder; Verruciform xanthoma; Biochemistry Genetics and Molecular Biology (all)030207 dermatology & venereal diseases0302 clinical medicinelcsh:QH301-705.5Verruciform xanthomaErythroplakiamedicine.diagnostic_testChronic graft versus-host-diseaseHematopoietic Stem Cell TransplantationMED/28 - MALATTIE ODONTOSTOMATOLOGICHEGeneral MedicineMiddle AgedPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.anatomical_structure030220 oncology & carcinogenesisOral erythroplakiamedicine.symptommedicine.medical_specialtyGeneral Biochemistry Genetics and Molecular BiologyOral potential malignant disorder03 medical and health sciencesTongueBiopsymedicineXanthomatosisLS7_3Humanslcsh:Science (General)Biochemistry Genetics and Molecular Biology (all)business.industrylcsh:RAmbientaleNodule (medicine)medicine.diseaseDermatologystomatognathic diseaseslcsh:Biology (General)ErythroplasiaChronic DiseaseHard palatebusinessMouth DiseasesOral medicineErythroplakialcsh:Q1-390
researchProduct

Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Regist…

2019

BACKGROUND: We compared, through the European Liver Transplant Registry, long-term liver transplantation outcomes with prolonged-release tacrolimus (PR-T) versus immediate-release tacrolimus (IR-T)-based immunosuppression. This retrospective analysis comprises up to 8-year data collected between 2008 and 2016, in an extension of our previously published study. METHODS: Patients with <1 month follow-up were excluded; patients were propensity score matched for baseline characteristics. Efficacy measures included: univariate/multivariate analyses of risk factors influencing graft/patient survival up to 8 years posttransplantation, and graft/patient survival up to 4 years with PR-T versus IR-T.…

Graft RejectionMalemedicine.medical_specialtyTime FactorsDrug Compoundingmedicine.medical_treatmentCalcineurin InhibitorsMedizinMEDLINEchemical and pharmacologic phenomenaLiver Transplant030230 surgeryLiver transplantationRisk AssessmentTacrolimusall contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA)03 medical and health sciences0302 clinical medicineRisk FactorsProlonged releaseInternal medicinemedicineHumansAged; Calcineurin Inhibitors; Delayed-Action Preparations; Drug Compounding; Europe; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; Liver TransplantationRegistriesAgedRetrospective StudiesTransplantationbusiness.industryGraft SurvivalImmunosuppressionRetrospective cohort studyMiddle AgedTacrolimusSettore MED/18Liver Transplantation3. Good healthEuropeTreatment Outcomesurgical procedures operativeDelayed-Action PreparationsFemale030211 gastroenterology & hepatologyTransplant patientbusinessRisk assessmentImmunosuppressive AgentsTransplantation
researchProduct

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry

2021

Heart retransplantation (ReHT) is controversial in the current era. The aim of this study was to describe and analyze the results of ReHT in Spain. Methods We performed a retrospective cohort analysis from the Spanish Heart Transplant Registry from 1984 to 2018. Data were collected on donors, recipients, surgical procedure characteristics, immunosuppression, and survival. The main outcome was posttransplant all-cause mortality or need for ReHT. We studied differences in survival according to indication for ReHT, the time interval between transplants and era of ReHT. Results A total of 7592 heart transplants (HT) and 173 (2.3%) ReHT were studied (median age, 52.0 and 55.0 years, respectively…

Graft RejectionReoperationmedicine.medical_specialtyTrasplante cardiacoSurvivalmedicine.medical_treatmentRetrasplante cardiacoEnfermedad cardiovascularCardiac allograft vasculopathyCold Ischemia TimeHeart retransplantation Heart transplant Retrasplante cardiaco Supervivencia Survival Trasplante cardiacoCirugíaInternal medicinemedicineHumansRegistriesTrasplante de corazónBalloon pumpPrimary graft failureRetrospective StudiesMechanical ventilationHeart transplantsSupervivenciabusiness.industryAnálisis de datosImmunosuppressionRetrospective cohort studyGeneral MedicineMiddle AgedSpainHeart retransplantationCardiologyHeart TransplantationHeart transplantbusiness
researchProduct

The effect of ischemia/reperfusion on the kidney graft.

2014

Ischemia/reperfusion injury is an unavoidable companion after kidney transplantation and influences short-term as well as long-term graft outcome. Clinically ischemia/reperfusion injury is associated with delayed graft function, graft rejection, and chronic graft dysfunction. Ischemia/reperfusion affects many regulatory systems at the cellular level as well as in the renal tissue that eventually result in a distinct inflammatory reaction of the kidney graft.Underlying factors include energy metabolism, cellular changes of the mitochondria and cellular membranes, initiation of different forms of cell death-like apoptosis and necrosis together with a recently discovered mixed form termed necr…

Graft RejectionTransplantationmedicine.medical_specialtyKidneyGraft dysfunctionGraft rejectionbusiness.industryT-LymphocytesIschemiamedicine.diseaseKidney TransplantationDelayed Graft FunctionImmunity InnateSurgerysurgical procedures operativemedicine.anatomical_structureImmunityReperfusion InjurymedicineImmunology and AllergyAnimalsHumansbusinessReperfusion injuryKidney transplantationCurrent opinion in organ transplantation
researchProduct

Tierexperimentelle Untersuchungen zum gestielten D�nndarm-transplantat als partieller extrahepatischer Gallengangsersatz

1991

Mit einem gestielten Dunndarmpatch konnte in Einzelfallen eine Gallengangsstriktur dauerhaft erweitert werden. Man beobachtet jedoch eine Dilatation des Patches, deren Ursache ebenso wie deren Folgen auf die Leberfunktion bislang ungeklart sind. Mit einem gestielten Dunndarmpatch ist tierexperimentell ein partieller extrahepatischer Gallengangsersatz moglich. Eine Erweiterung des Patches wird regelmasig beobachlet. Ursache hierfur ist weder eine Denervation des Patches noch der intraduktale Gallengangsdruck, sondern moglicherweise ein Zug am Gefasstiel. Morphologische Veranderungen treten am Patch nach bis zu 15 Monaten nicht auf. Leberfunktionsstorungen konnen weder laborchemisch noch hist…

Gynecologymedicine.medical_specialtymedicine.anatomical_structurebusiness.industrySmall intestinal transplantationBile ductCardiothoracic surgeryMedicineSurgerybusinessPedicle graftAbdominal surgeryLangenbecks Archiv f�r Chirurgie
researchProduct